FDA Inspection 1251059 — Jennifer L. Miller, M.D.
The FDA completed an inspection of Jennifer L. Miller, M.D. on October 2, 2024 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 2, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gainesville, FL (United States)
Additional Details
Clinical Investigator (CI)